Acne Medicine Market Size Projected to Reach USD 23.33 Billion by 2034

The global acne medication market is valued at USD 14.86 billion in 2025 and is projected to grow to approximately USD 23.33 billion by 2034, registering a compound annual growth rate (CAGR) of 5.14% over the forecast period.

Ottawa, Sept. 01, 2025 (GLOBE NEWSWIRE) -- The global acne medication market size to rise from USD 14.13 billion in 2024 and is expected to reach around USD 23.33 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.14%, according to a study by Towards Healthcare, a sister company of Precedence Research.

The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ https://www.towardshealthcare.com/download-sample/5309

Key Takeaways

North America dominated the acne medicine market in 2023
Asia Pacific is the fastest-growing region in the acne medicine market.
By therapeutic class, the retinoid segment dominated the global acne medicine market in 2023.
Based on formulation, the topical medication segment dominated the acne medicine market in 2023.
Based on types, the prescription medicine segment dominated the acne medicine market.
Based on acne types, the non-inflammatory acne segment dominated the acne medicine market in 2023.
Based on distribution channels, the pharmacy and drug store segment dominated the acne medicine market in 2023.

Market Overview & Potential

As lifestyles change, people of all ages can develop skin problems like acne that require proper medications and treatments to prevent them from worsening. Dermatologists play a crucial role in providing suitable preventive measures to patients through topical medications, oral medications, and therapies. These medications help reduce excess oils and swelling caused by bacterial infections or other common issues. Topical medications often include retinoids, antibiotics, azelaic acid, salicylic acid, or dapsone gel. Oral medications may include combined oral contraceptives or anti-androgen agents.

Additionally, various therapies are available, such as light therapy, chemical peels, steroid injections, and more. In 2013, over 5.1 million people received medical treatment for acne, including children and adults. The demand for acne medications is growing rapidly, driving significant growth in the acne medicine market.

What is the Growth Potential Responsible for The Growth of The Acne Medicine Market?

The growth of the market is driven by the growing prevalence of acne due to various factors like stress, environmental factors, and hormonal imbalance, which increases the demand for medicine for treatment. The growing awareness of treatment and demand for technologically advanced therapies through integration of AI and telemedicine for remote consultations, which boosts the growth of the market. Other key drivers are the hormonal therapies demand, advancements treatment options, focus on clean and natural ingredients, and increased healthcare spending fuel the growth and expansion of the market.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

What Are the Growing Trends Associated with the Acne Medicine Market?

Increased demand for advanced therapies:

There is a growing demand for innovative solutions like biologics, light-based therapies, and new drug formulations that offer better results, improved patient tolerance, and reduced reliance on antibiotics for severe acne.

Focus on retinoids and combination therapies:

Retinoids are projected to see faster growth as demand increases for treating moderate to severe acne. The use of combination therapies is also on the rise, with treatments combining different types of agents for better efficacy.

Growing prevalence and awareness:

The increasing prevalence of acne, a common skin condition affecting many people globally, combined with rising skin awareness and cosmetic concerns, is a major driver of market growth.

Advancements in telemedicine:

The development of teledermatology and direct-to-consumer platforms is improving access to prescription acne care, especially in regions like India, where the market is rapidly expanding.

What Is the Growing Challenge in the Acne Medicine Market?

The key challenge which hinders the growth of the market is the adverse side effects associated with the medicines, like skin irritation or dizziness, lack of patient awareness of treatment option availability, availability of alternatives, high research and development costs, which affect the profitability and also result in high cost of final products, cost effectiveness, and treatment efficacy and duration. These factors limit the growth and expansion of the market.

Get the latest insights on life science industry segmentation with our Annual Membership: https://www.towardshealthcare.com/get-an-annual-membership

Regional Analysis

How Did North America Dominate the Acne Medicine Market?

North America dominated the acne medicine market in 2023. The growth of the market is driven by the high prevalence of acne, which drives the demand for treatments due to the growing focus on skincare treatment. Innovation in treatments, and strong pharmaceutical presence in North America, also engage in research and development fuels the growth of the market. The key players like Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Galderma SA, and Johnson & Johnson also play a crucial role in the growth and expansion of the market through innovation and research.

What Made the Asia Pacific Significantly Grow in The Acne Medicine Market?

Asia Pacific is the fastest-growing region in the acne medicine market. The growth of the market in the region is driven by the rising demand for patches due to their properties and benefits offered, which fuel the growth of the market. Other key drivers are the dominant distribution channels like E-commerce, and strategic partnerships to expand product portfolios boost the growth of the market. Key players like Ranbaxy Laboratories, Roche Diagnostics, Johnson & Johnson, and Galderma play a significant role in the growth of the market.

Segmental Insights

By therapeutic class,

The retinoid segment dominated the global acne medicine market in 2023. Retinol plays a crucial role in the acne medicine market as a widely used therapeutic class known for promoting cell turnover and preventing clogged pores. It helps reduce acne lesions, improve skin texture, and minimize scars. Retinol-based products are commonly prescribed for mild to moderate acne and are also incorporated into over-the-counter skincare formulations, making them a versatile solution for long-term acne management across diverse consumer groups.

Based on the formulation,

The topical medication segment dominated the acne medicine market in 2023. Topical medications are the most common formulation in acne treatment, offering direct application to affected areas with minimal systemic effects. These include creams, gels, and ointments containing retinoids, benzoyl peroxide, or antibiotics. Their ease of use, accessibility, and effectiveness in treating mild to moderate acne make them highly popular. Topical formulations are widely prescribed by dermatologists and are also available as over-the-counter products for self-care and prevention.

Become a valued research partner with us - https://www.towardshealthcare.com/schedule-meeting

Based on types,

The prescription medicine segment dominated the acne medicine market. Prescription medicines hold a significant share of the acne medicine market, targeting moderate to severe cases. These include stronger retinoids, oral antibiotics, and hormonal therapies prescribed under medical supervision. Prescription products offer higher efficacy and are tailored to individual patient needs, often used when over-the-counter solutions are insufficient. Growing dermatological consultations and awareness of advanced treatments continue to expand the demand for prescription acne medicines globally.

Based on acne types,

The non-inflammatory acne segment dominated the acne medicine market in 2023. The treatment of non-inflammatory acne, such as blackheads and whiteheads, is a key focus in the acne medicine market. Medications targeting excess sebum production and clogged pores, like retinoids and exfoliating agents, are highly effective. Demand is driven by a growing teenage population, lifestyle changes, and skincare awareness. Non-inflammatory acne treatments are often the first step before progressing to advanced solutions for inflammatory or severe acne types.

Based on distribution channels,

The pharmacy and drug store segment dominated the acne medicine market in 2023. Pharmacies and drug stores serve as primary distribution channels for acne medicines, offering both prescription and over-the-counter products. Their accessibility, immediate availability, and wide product variety make them the most preferred point of purchase. Consumers rely on these outlets for professional advice and convenient access to dermatology-recommended products. Growing retail pharmacy chains and the expansion of drug stores in urban and rural areas further strengthen this distribution segment.

Recent Developments

In April 2024, Bausch Health Companies Inc. announced the launch of its topical prescription treatment for acne vulgaris named PrARAZLO (tazarotene lotion, 0.045%). It is available to patients through BC PharmaCare, which is the public drug program of British Columbia.

Browse More Insights of Towards Healthcare:

The global AI in telehealth and telemedicine market is experiencing remarkable growth. From a valuation of US$ 3.89 billion in 2024, it surged to US$ 5.3 billion in 2025 and is projected to reach approximately US$ 86.31 billion by 2034, expanding at an impressive CAGR of 36.35% over the forecast period.

Meanwhile, the nuclear medicine software market is steadily expanding. Starting at US$ 895.04 million in 2024, it grew to US$ 975.15 million in 2025 and is expected to cross US$ 2.1 billion by 2034, growing at a CAGR of 8.95%.

In the U.S. life sciences sector, the market is poised for significant revenue growth, with projections suggesting it could reach hundreds of millions between 2025 and 2034.

The nuclear medicine equipment market also shows consistent growth. From US$ 6.33 billion in 2024, it is anticipated to reach US$ 6.62 billion in 2025 and US$ 9.91 billion by 2034, supported by a CAGR of 4.58%.

The global portable ultrasound market continues its upward trajectory. Valued at US$ 2.35 billion in 2024, it is expected to grow to US$ 2.56 billion in 2025 and hit US$ 5.53 billion by 2034, reflecting a CAGR of 8.94%.

The precision diagnostics and medicine market is expanding rapidly, reaching USD 146.88 billion in 2024 and growing to USD 162.88 billion in 2025. By 2034, the market is projected to hit USD 412.95 billion, with a CAGR of 10.89% over the forecast period.

The synthetic tissue engineering market is on a strong growth path as well. From US$ 1.51 billion in 2024, it rose to US$ 1.72 billion in 2025 and is projected to reach US$ 5.61 billion by 2034, at a CAGR of 14.14%.

Similarly, the glycobiology market is expanding, starting from US$ 0.65 billion in 2024, growing to US$ 0.75 billion in 2025, and expected to reach US$ 2.63 billion by 2034, reflecting a CAGR of 14.91%.

The life science lab equipment market continues its steady growth, valued at USD 57.71 billion in 2024, rising to USD 61.08 billion in 2025, and projected to reach USD 101.37 billion by 2034, expanding at a CAGR of 5.84%.

Finally, the NGS-based RNA sequencing market is witnessing significant momentum. From USD 3.74 billion in 2024, it grew to USD 4.49 billion in 2025 and is forecasted to reach USD 23.52 billion by 2034, with a robust CAGR of 20.1%.

Acne Medicine Market Key Players

GlaxoSmithKline
Bausch Health Companies Inc.
Teva Pharmaceuticals
Bayer AG
Sun Pharmaceuticals
Botanix Pharmaceuticals
Allergan
Zydus LifeSciences Limited
Johnson and Johnson
Pfizer Inc.
Cosmo Pharmaceuticals

Segments Covered in The Report

By Therapeutic Class

Retinoid
Topical and Combination Retinoid
Oral Retinoid

By Formulation

Topical Medication
Oral Medication
Antibiotics

By Type

Prescription Medicines
Oral Antibiotics
Hormonal Treatments
Oral Contraceptive Tablets

By Acne Type

Non-inflammatory Acne
Inflammatory Acne

By Distribution Channel

Retail Store
Pharmacy and Drug Store

By Region

North America
- U.S.
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Thailand
Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
Latin America
- Brazil
- Mexico
- Argentina
Middle East and Africa (MEA)
- South Africa
- UAE
- Saudi Arabia
- Kuwait

Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5309

Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.

Access the Dashboard: https://www.towardshealthcare.com/access-dashboard

Become a valued research partner with us - https://www.towardshealthcare.com/schedule-meeting

About Us

Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth.

You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com

Europe Region: +44 778 256 0738

North America Region: +1 8044 4193 44

APAC Region: +91 9356 9282 04

Web: https://www.towardshealthcare.com

Our Trusted Data Partners

Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.